Printable GLP-1 Medication Comparison Chart: Semaglutide Vs Tirzepatide And More











If you're researching GLP-1s, you've probably noticed two things fast: (1) the names are confusing (Ozempic vs Wegovy vs Rybelsus), and (2) the "best" option depends on details that aren't obvious in a 30‑second scroll. A GLP-1 medication comparison chart printable can help you see the big picture, what's used for type 2 diabetes vs weight management, how often you dose, and what side effects to expect, so you can have a smarter, calmer conversation with your prescriber.
Below you'll find a practical one-page-style comparison (in table form), plus a decision checklist and printing tips. It's not meant to replace medical advice, it's meant to keep you organized when your brain is juggling dose titration, GI symptoms, insurance rules, and (for many women) perimenopause/menopause changes that affect appetite, reflux, and constipation.
How To Use This Printable Chart (And What It Can And Can’t Tell You)
A printable chart is most useful when you treat it like a conversation tool, something you bring to your appointment (or keep on your fridge) to track what you're taking, what you're feeling, and what you might try next.
What it can do:
- Help you compare indications (type 2 diabetes vs weight management), dosing frequency, and delivery method (pen injection vs oral tablet).
- Make it easier to spot why two people on "semaglutide" can have totally different experiences (Ozempic and Wegovy are different brands/doses/indications).
- Give you a structured way to weigh tradeoffs: convenience vs tolerability vs expected weight/A1C changes.
What it can't do:
- Predict exactly how you will respond (GI side effects, appetite suppression, and weight loss vary a lot).
- Tell you what your insurance will cover this month.
- Replace personalized medical guidance, especially if you have a history of pancreatitis, gallbladder issues, severe reflux/IBS, or you're on multiple meds that affect stomach emptying.
What To Compare Before You Switch Or Start A GLP-1
Before you start, switch, or "upgrade," compare these categories (they're mirrored in the chart below):
- Your goal: A1C lowering, weight management, or both.
- Dosing cadence: weekly vs daily, this matters more than people admit.
- Titration pace: how slowly you can step up to reduce nausea, constipation, and bloating.
- Delivery preference: injection comfort, travel schedule, and whether an oral option is important.
- GI sensitivity: baseline constipation, IBS, reflux, or a history of nausea.
- Cardio-kidney priorities: if you have established cardiovascular disease or CKD risk factors, you'll want to discuss outcome data with your prescriber.
- Practical constraints: pharmacy availability/shortages, prior authorizations, and cost.
When To Ask Your Prescriber For A Personalized Recommendation
Use the chart, but ask for a tailored plan if any of these are true:
- You have type 2 diabetes with frequent hypoglycemia (especially if you also use insulin or sulfonylureas).
- You've had severe GERD, IBS flares, or you're already struggling with constipation.
- You're in perimenopause/menopause and noticing appetite, sleep, and GI changes, your dose titration strategy may need to be slower.
- You've had gallbladder disease, pancreatitis, or a strong family history of medullary thyroid cancer/MEN2 (GLP‑1 class warnings apply).
- You're considering compounded products. Some people use compounded semaglutide for cost/access, but it's not the same as an FDA-approved brand product, your clinician should help you assess safety and sourcing.
If digestive side effects are your main barrier, it's also worth exploring gut-support strategies alongside your prescription, Casa de Sante focuses specifically on physician-formulated digestive health support for GLP‑1 users, including low FODMAP options and tools for sensitive stomachs (helpful if nausea or bloating is derailing your consistency).
GLP-1 Medications Included In This Comparison
This guide focuses on the most commonly discussed GLP‑1 (and related) options you're likely to encounter in real life: semaglutide and tirzepatide, plus a couple of older/less-common medications.
Semaglutide (Ozempic, Wegovy, Rybelsus)
Semaglutide is a GLP‑1 receptor agonist used in different branded forms:
- Ozempic: typically prescribed for type 2 diabetes.
- Wegovy: the semaglutide brand approved for chronic weight management (specific eligibility is usually based on BMI criteria and comorbidities).
- Rybelsus: an oral semaglutide tablet used for type 2 diabetes.
In practice, people like semaglutide for the weekly routine (Ozempic/Wegovy) and the robust outcomes. Others prefer to avoid injections and ask about Rybelsus, though the daily dosing rules (timing, empty stomach) can be finicky.
Tirzepatide (Mounjaro, Zepbound)
Tirzepatide is a dual GIP/GLP‑1 medication (often discussed alongside GLP‑1s because it's used similarly):
- Mounjaro: type 2 diabetes.
- Zepbound: chronic weight management.
Head-to-head and comparative data have generally shown greater average A1C and weight loss with tirzepatide vs semaglutide in many populations, though "average" doesn't mean "guaranteed," and GI tolerability still matters.
Liraglutide And Exenatide (Less-Common Options)
You may still see these in certain scenarios:
- Liraglutide (Victoza for T2D: Saxenda for weight management) is commonly daily injection, which some people find annoying, but others like the ability to adjust/stop more quickly if side effects hit.
- Exenatide (e.g., Byetta: some formulations are less commonly used today) may come up depending on your history and insurance. It's typically not the first option people ask for in 2026, but it's part of the "GLP‑1 family tree."
GLP-1 Medication Comparison Chart (Printable)
Below is a practical comparison you can print. It's intentionally "clinic-friendly", the kind of grid that helps you ask better questions without drowning you in jargon.
Important: Dosing and titration schedules can vary by product, indication, and your prescriber's approach. Always follow your specific prescription.
Indications: Type 2 Diabetes Vs Weight Management
Use this to make sure you're comparing the right brand to your goal.
| Medication (Brand examples) | Primary indications (typical) | Notes to discuss with your clinician |
|---|---|---|
| Semaglutide (Ozempic) | Type 2 diabetes | Often chosen for A1C lowering + weight benefit: may have cardio-renal considerations depending on your risk profile. |
| Semaglutide (Wegovy) | Chronic weight management | Same active ingredient as Ozempic, but dosing/indication differ. |
| Semaglutide (Rybelsus) | Type 2 diabetes | Oral option: adherence depends on strict administration timing. |
| Tirzepatide (Mounjaro) | Type 2 diabetes | Dual GIP/GLP‑1: often strong A1C + weight outcomes. |
| Tirzepatide (Zepbound) | Chronic weight management | Weekly injection: similar "family" to Mounjaro with different indication/labeling. |
| Liraglutide (Victoza/Saxenda) | T2D (Victoza), weight management (Saxenda) | Daily injection: sometimes used when weekly meds aren't a fit. |
| Exenatide (e.g., Byetta) | T2D | Less common now: still relevant for some insurance pathways. |
Dosing Schedule, Titration, And Typical Dose Ranges
Think "how often" + "how slowly can I move up without feeling awful?"
| Medication | Typical dosing frequency | Titration pattern (high level) | Typical dose range (varies by indication) |
|---|---|---|---|
| Semaglutide (SC) Ozempic/Wegovy | Weekly injection | Start low, increase stepwise every few weeks if tolerated | ~0.25 mg up to 2.0 mg (Ozempic) or up to 2.4 mg (Wegovy) |
| Semaglutide (oral) Rybelsus | Daily tablet | Gradual increases after a starter period | Commonly 7–14 mg daily after starting dose (per labeling) |
| Tirzepatide (SC) Mounjaro/Zepbound | Weekly injection | Start low, increase stepwise (often 2.5 mg increments) | Often 2.5–15 mg weekly (depending on label/goal) |
| Liraglutide (SC) Victoza/Saxenda | Daily injection | Slow step-up to target dose | Varies by product/indication: typically up to 1.8 mg (Victoza) or 3 mg (Saxenda) |
| Exenatide (SC) Byetta | Twice daily (Byetta) | Lower starting dose: adjust as needed | Varies: older regimen-dependent |
Delivery: Pen Injection Vs Oral Tablet
Delivery isn't just preference, it affects consistency, travel, and how you manage side effects.
- Weekly pen injection: Ozempic, Wegovy, Mounjaro, Zepbound (most people like the simplicity).
- Daily injection: Saxenda/Victoza (more frequent, but sometimes easier to stop quickly if you're having GI trouble).
- Oral tablet: Rybelsus (no needle, but requires careful timing, usually taken on an empty stomach with a small amount of water and waiting before food/other meds).
Expected Benefits: A1C, Weight Loss, And Cardio-Kidney Outcomes
You'll see numbers quoted online like they're promises. They're not. But they're still useful for "directionally, what tends to happen in studies?"
| Medication | A1C lowering (general expectation) | Weight loss (general expectation) | Cardio-kidney notes (high level) |
|---|---|---|---|
| Semaglutide | Strong A1C reduction in T2D | Many people see meaningful loss: Wegovy trials show ~15% average loss over longer durations in some studies | GLP‑1 class has evidence supporting CV benefit in select populations: discuss your personal risk profile |
| Tirzepatide | Often very strong A1C reduction | Some trials show higher average loss vs semaglutide (commonly cited up to ~20–25% in certain study designs/durations) | Outcome data continue evolving: your clinician can match this to your CV/renal risks |
| Liraglutide | Solid A1C reduction | Weight loss tends to be more modest on average (often cited ~8% in weight management studies) | Has CV outcomes data in diabetes populations: discuss whether it fits your goals |
Common Side Effects And GI Tolerability Notes
GI symptoms are the #1 reason people quit early. The trick is preventing the "week 2 crash" where nausea and constipation pile up.
| Medication | Common GI effects | Tolerability notes |
|---|---|---|
| Semaglutide | Nausea, diarrhea, constipation, vomiting, reduced appetite | Slower titration often improves tolerability: reflux can flare for some people as gastric emptying slows |
| Tirzepatide | Nausea, diarrhea, constipation, decreased appetite | Strong appetite suppression can make it easier to under-eat protein/fluids, then constipation hits |
| Liraglutide | Nausea, constipation, diarrhea | Daily dosing can feel "more adjustable," but nausea can still be significant early on |
| Exenatide | Nausea, GI upset | Less commonly used: side-effect profile still matters if it's what insurance covers |
Contraindications, Warnings, And Key Drug Interactions
This is the "don't skip" section.
- Class warnings/contraindications (discuss with your prescriber): history of medullary thyroid carcinoma or MEN2: severe hypersensitivity: and caution with pancreatitis history.
- Gallbladder risk: rapid weight loss and GLP‑1s can be associated with gallbladder issues, report right-upper-quadrant pain, fever, or persistent vomiting.
- Kidney concerns: dehydration from vomiting/diarrhea can worsen kidney function, hydration is not optional.
- Drug interactions (practical): because GLP‑1s slow gastric emptying, they can affect how quickly some oral meds are absorbed. If you take thyroid hormone, antibiotics, pain meds, or meds that must be timed with meals, ask specifically how to schedule them.
- Hypoglycemia risk: GLP‑1s alone have low hypoglycemia risk, but risk rises if combined with insulin or sulfonylureas, your prescriber may adjust doses.
If you're prone to bloating/IBS symptoms, pairing your prescription with a gut-support plan (like a low FODMAP strategy and GLP‑1-friendly supplement approach) can make staying on therapy easier, this is exactly the niche Casa de Sante was built around.
Choosing The Best Fit: A Practical Decision Checklist
You don't need a perfect choice, you need a workable choice you can stay consistent with for months.
If You're New To GLP-1s
Use this quick checklist:
- Do you need type 2 diabetes control, weight management, or both?
- Would weekly dosing improve adherence for you compared to daily?
- Are you okay with an injection pen, or is an oral option a must?
- What's your baseline GI situation: constipation, IBS, reflux, nausea-prone?
- Can you commit to the basics that reduce side effects: protein, fluids, electrolytes, and fiber (strategically, not aggressively)?
- What does your insurance actually cover today, and what prior auth steps are required?
If You're Switching From Semaglutide To Tirzepatide (Or Vice Versa)
Switching can be straightforward, but don't freestyle it.
- Ask how your clinician wants you to transition doses (some switches include a washout period: others don't).
- Expect your GI system to "notice" the change even if you've been on a GLP‑1 already.
- If you had side effects before, request a slower titration from the start rather than trying to push through.
- Keep your chart handy and track: dose day, nausea level, bowel movements, reflux symptoms, and protein/fluid intake.
If You Have IBS, Reflux, Or A Sensitive Stomach
You're not "failing" GLP‑1 therapy if your gut is loud. You just need a more deliberate plan.
- Start low and titrate slowly, your prescriber can sometimes hold you at a dose longer.
- Favor smaller meals: high-fat meals are common nausea/reflux triggers.
- Consider whether your diet pattern is accidentally high FODMAP (onions/garlic, certain protein bars, sugar alcohols) and worsening bloating.
- If constipation is your baseline, plan for it before dose escalation.
Casa de Sante's focus on IBS management and low FODMAP meal plans can be especially relevant here, because a lot of GLP‑1 "bloat" is a perfect storm of slowed gastric emptying + fermentable carbs + lower fluid intake.
If You're In Perimenopause Or Menopause
This is where the internet gets weirdly unhelpful. Your hormones affect sleep, stress reactivity, GI motility, and body composition, so your GLP‑1 experience may not match your friend's.
- Prioritize protein and resistance training to protect lean mass (especially important as estrogen shifts).
- Watch constipation and reflux, both can worsen during hormonal transitions and with GLP‑1s.
- If you're considering or already using hormone therapy, ask your clinician about timing, symptom tracking, and whether nausea/reflux changes align with dose increases.
- Track more than weight: waist measurement, strength, sleep quality, and GI regularity often tell the real story.
How To Reduce GLP-1 Side Effects (Especially Nausea, Constipation, And Bloating)
Most side-effect reduction comes down to three levers: meal size, hydration/electrolytes, and bowel regularity. Simple, yes. Easy? Not always.
Food Strategy: Smaller Meals, Protein Targets, And Trigger Foods
Try this approach for the first 4–8 weeks (and any time you titrate up):
- Go smaller than you think you need. A "normal" portion can become a nausea bomb once gastric emptying slows.
- Protein first. Aim for a protein anchor at each meal (Greek yogurt, eggs, chicken, tofu, protein shake). If you're struggling, a low FODMAP protein powder can be gentler than bars loaded with sugar alcohols.
- Limit high-fat, greasy meals early on, common triggers for nausea and reflux.
- Watch carbonated drinks if bloating is an issue.
- If you suspect IBS overlap, do a quick audit for common bloat triggers: onions/garlic, large amounts of beans, inulin/chicory fiber, and sugar alcohols.
Fiber, Electrolytes, And Hydration Without Worsening Symptoms
A lot of GLP‑1 constipation is really "low intake constipation", less food, less fluid, less salt.
- Hydration: steady sipping beats chugging. If plain water makes you queasy, try cold water, herbal tea, or diluted electrolyte drinks.
- Electrolytes: especially helpful if you're eating less and feeling lightheaded. Choose options that don't rely heavily on sugar alcohols if you bloat easily.
- Fiber: add it gradually. For sensitive stomachs, some fibers are better tolerated than others: increasing too fast can backfire and spike gas/bloating.
Managing Constipation Safely While On GLP-1s
Constipation is common, and solvable, but don't wait until it's severe.
- Build a routine: same time each morning, warm drink, short walk.
- Prioritize fiber from food (kiwi, oats, chia, if tolerated) and adequate fluids.
- If needed, ask your clinician about stool softeners or osmotic laxatives and what's appropriate for you.
- Movement matters: even a 10–15 minute walk after meals can help motility and reflux.
If you have IBS-C or you're highly sensitive, a structured approach (like Casa de Sante's digestive health tools and meal guidance) can reduce trial-and-error, because guessing wrong with fiber is…unpleasant.
When Side Effects Mean You Should Pause And Call Your Clinician
Call your clinician promptly if you have:
- Persistent vomiting or inability to keep fluids down
- Severe abdominal pain (especially with fever)
- Signs of dehydration (dizziness, very dark urine, fainting)
- Severe constipation with pain, no bowel movement for several days even though home measures
- New or worsening reflux that interferes with eating/sleep
And if you feel "scared to take the next dose," that's a sign to pause and get guidance, not power through.
How To Print And Keep The Chart Handy
A printable chart only works if you actually use it, so make it frictionless.
Print Settings For A One-Page Version
For a clean one-page printout:
- Set orientation to Landscape.
- Choose Fit to page (or 90–95% scale if your printer shrinks too aggressively).
- Turn on print background only if your browser uses shading that improves readability.
- If you're printing from your phone, email the page to yourself and print from a desktop to keep the table from breaking across pages.
What To Track Weekly Alongside The Chart
Next to your printed comparison, track a short weekly log (takes 2 minutes):
- Dose and date/time taken
- Weight trend (weekly average, not daily noise)
- Waist measurement (optional, but useful)
- A1C/glucose notes (if you monitor)
- Nausea (0–10), reflux (0–10), bloating (0–10)
- Bowel movements per week + stool consistency
- Protein estimate and fluids/electrolytes
This is the stuff that makes your next appointment dramatically more productive, because you're not relying on memory from "that rough Tuesday two weeks ago."
Conclusion
A GLP-1 medication comparison chart printable won't choose a medication for you, but it will keep you grounded in the factors that actually matter: your indication, your dosing preference, your side-effect pattern, and your lifestyle. If you're deciding between semaglutide and tirzepatide, the "best" answer is usually the one you can tolerate, access, and stick with long enough to get the benefits.
Print the chart, circle what matters most (weekly vs daily, oral vs injection, IBS/reflux risk, menopause-related constipation), and bring it to your prescriber. And if GI symptoms are the speed bump, don't ignore them, build a support plan early. With the right titration pace, food strategy, and gut-friendly tools, you can often turn GLP‑1 side effects from "dealbreaker" into "manageable."
Frequently Asked Questions (GLP-1 Medication Comparison Chart Printable)
What is a GLP-1 medication comparison chart printable, and how do I use it?
A GLP-1 medication comparison chart printable is a one-page reference that helps you compare indications (type 2 diabetes vs weight management), dosing frequency (weekly vs daily), and delivery (pen injection vs oral tablet). Use it as an appointment “conversation tool” and a weekly log for dose day, GI symptoms, and progress.
Which GLP-1 meds are included in a GLP-1 medication comparison chart printable?
Most printable GLP-1 comparison charts cover the commonly discussed options: semaglutide (Ozempic for type 2 diabetes, Wegovy for weight management, and Rybelsus as an oral option for type 2 diabetes), tirzepatide (Mounjaro for type 2 diabetes and Zepbound for weight management), plus liraglutide and exenatide as less-common alternatives.
Ozempic vs Wegovy vs Rybelsus: what’s the difference if they’re all semaglutide?
They share the same active ingredient (semaglutide), but differ in FDA indication, dosing, and delivery. Ozempic is typically used for type 2 diabetes, Wegovy is approved for chronic weight management with different dosing targets, and Rybelsus is a daily oral tablet that requires strict timing (empty stomach, small water amount, wait before food/meds).
Is tirzepatide better than semaglutide for weight loss and A1C?
In many head-to-head and comparative studies, tirzepatide (Mounjaro/Zepbound) shows greater average A1C reduction and weight loss than semaglutide, but “average” isn’t guaranteed. GI tolerability, titration speed, access/insurance, and your goals (diabetes vs weight management) often decide what’s “best” for you.
What should I compare before starting or switching GLP-1 medications?
Compare your goal (A1C lowering, weight management, or both), dosing cadence (weekly vs daily), titration pace, and delivery preference (injection vs oral). Also factor in GI sensitivity (constipation, IBS, reflux), cardio-kidney priorities, and practical constraints like shortages, prior authorizations, and cost. Bring your printable chart to your prescriber.
How can I reduce GLP-1 side effects like nausea, constipation, and bloating?
Start low and titrate slowly, eat smaller meals, and put protein first to avoid nausea “crashes.” Hydrate steadily and consider electrolytes if intake drops. Add fiber gradually (too fast can worsen bloating), move daily (short walks help), and call your clinician for persistent vomiting, severe abdominal pain, dehydration signs, or severe constipation lasting days.






